— Know what they know.
Not Investment Advice

IKT Short Interest

Inhibikase Therapeutics, Inc.
1W: -8.2% 1M: -23.4% 3M: -29.0% YTD: -19.5% 1Y: +1.9% 3Y: +70.7% 5Y: -86.4%
$1.57
+0.05 (+3.29%)
 
Weekly Expected Move ±8.0%
$1 $1 $2 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 26 · $219.1M mcap · 171M float · 0.428% daily turnover · Short 48% of daily vol
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z'' 15.72.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Short Volume Summary

2026-10-26
45.5%
Short Ratio
of total volume
49.9%
20-Day Avg
51.7%
50-Day Avg
▲ Rising
5-Day Trend
0.1M
Short Volume
0.3M
Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-26
ExchangeShort VolumeTotal VolumeShort %
NASDAQ 105,965 245,432 43.2%
NYSE 8,834 12,723 69.4%
BATS 4,743 4,798 98.9%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms